Related Experiment Video
Updated: Feb 12, 2026

Echocardiographic Characterization of Left Ventricular Structure, Function, and Coronary Flow in Neonate Mice
Published on: April 7, 2022
Synergy of Coronary Revascularization and Optimal Drug Therapy in Patients With Ischemic Cardiomyopathy and Reduced
1International Cardiology Center of the Directorate of International Medical Centers, Ashgabat.
Insights
Combining percutaneous coronary intervention (PCI) with optimal medical therapy (OMT) significantly improves outcomes for patients with ischemic cardiomyopathy (ICM). This approach enhances left ventricular function and reduces mortality and hospitalizations.
Area of Science:
- Cardiology
- Heart Failure Research
- Interventional Cardiology
Background:
- Ischemic cardiomyopathy (ICM) with reduced left ventricular ejection fraction (LVEF) is a severe form of chronic heart failure (CHF) with high mortality.
- Optimal treatment strategies, particularly the role of coronary revascularization alongside optimal medical therapy (OMT), are under active investigation.
- Understanding the impact on left ventricular (LV) reverse remodeling and long-term prognosis is crucial.
Purpose of the Study:
- To evaluate the clinical, functional, and prognostic outcomes of combining percutaneous coronary intervention (PCI) with OMT in patients with ICM and reduced LVEF.
- To assess the effect of PCI+OMT on LV reverse remodeling.
- To compare outcomes between patients treated with PCI+OMT versus OMT alone.
Main Methods:
- Retrospective cohort study of 561 patients with ICM and LVEF <40%.
- Patients were divided into a revascularization group (PCI+OMT, n=281) and an OMT group (n=280).
- Transthoracic echocardiography (ECHO) was used to assess cardiac structure and function over a 24-month follow-up period.
Main Results:
- The PCI+OMT group showed significantly greater improvement in LVEF (+10.7% vs. +2.1%) and a lower proportion of severe mitral regurgitation (5.3% vs. 16.1%) at 24 months.
- Overall mortality was significantly lower in the PCI+OMT group (10.7% vs. 23.2%).
- CHF-related hospitalization rates were also significantly reduced in the PCI+OMT group (17.8% vs. 33.9%).
Conclusions:
- The combination of PCI and OMT promotes significant recovery of myocardial contractility and LV reverse remodeling.
- This integrated approach leads to regression of functional mitral regurgitation.
- PCI+OMT significantly reduces mid-term overall mortality and hospitalizations due to decompensated CHF.
Aim:
To evaluate the clinical, functional and prognostic outcomes, including left ventricular (LV) reverse remodeling, of combining percutaneous coronary intervention (PCI) with optimal medical therapy (OMT) in patients with ischemic cardiomyopathy (ICM) and reduced left ventricular ejection fraction (LVEF).
Material And Methods:
ICM with significantly reduced LVEF remains one of the severe forms of chronic heart failure (CHF), associated with a high risk of adverse outcomes. The choice of the optimal treatment strategy, coronary revascularization in addition to intensive medical therapy, is a subject of active discussion and requires further study, especially regarding its effect on LV reverse remodeling and long-term prognosis. This retrospective cohort study included 561 patients with ICM and LVEF <40%. The follow-up lasted from 2014 through 2024. 74% of the patients were men aged 61.4±8.7 years. Patients were divided into a revascularization group (PCI+OMT, n=281) and an OMT group (n=280). The structural and functional state of the heart was assessed using transthoracic echocardiography (ECHO) with standard protocols.
Results:
The OMT group had a significantly higher EuroSCORE II surgical risk (4.0±1.9% vs. 3.0±1.5% in the PCI+OMT group; p<0.05), a greater prevalence of stage III or higher chronic kidney disease (35.7% vs. 17.8%; p<0.05), and more severe LV dilatation (LV end-diastolic volume 265±54 ml vs. 245±45 ml; p<0.05). The PCI+OMT group presented with significantly higher anatomical lesion complexity compared to the OMT group (SYNTAX Score 33.5±8.8 vs. 28.9±9.7, p<0.05). At the 24-month follow-up, the PCI+OMT group demonstrated a superior improvement in LVEF (+10.7±6.8% vs. +2.1±4.5%, p<0.001). The proportion of patients with severe mitral regurgitation (III+) was lower in the PCI+OMT group (5.3% vs. 16.1%, p<0.001), and overall mortality was 10.7% vs. 23.2% in the OMT group (p<0.001). The CHF-related hospitalization rate was also significantly lower in the PCI+OMT group than in the OMT group (17.8% vs. 33.9%; p<0.001).
Conclusion:
The combination of PCI and OMT is associated with a pronounced recovery of myocardial contractility, reverse LV remodeling, and regression of functional mitral regurgitation. The structural changes in the myocardium achieved through the integrative approach translate into a significant reduction in overall mortality and hospitalizations rates due to decompensated CHF during mid-term follow-up.
More Related Videos
06:07Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart
Published on: September 2, 2021
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Drug Therapy
Antianxiety Medications
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients